343 related articles for article (PubMed ID: 37091854)
1. Anoikis in phenotypic reprogramming of the prostate tumor microenvironment.
Nepali PR; Kyprianou N
Front Endocrinol (Lausanne); 2023; 14():1160267. PubMed ID: 37091854
[TBL] [Abstract][Full Text] [Related]
2. Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?
Rennebeck G; Martelli M; Kyprianou N
Cancer Res; 2005 Dec; 65(24):11230-5. PubMed ID: 16357123
[TBL] [Abstract][Full Text] [Related]
3. Cell death under epithelial-mesenchymal transition control in prostate cancer therapeutic response.
Begemann D; Anastos H; Kyprianou N
Int J Urol; 2018 Apr; 25(4):318-326. PubMed ID: 29345000
[TBL] [Abstract][Full Text] [Related]
4. Profiling Prostate Cancer Therapeutic Resistance.
Wade CA; Kyprianou N
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562686
[TBL] [Abstract][Full Text] [Related]
5. Targeting anoikis resistance in prostate cancer metastasis.
Sakamoto S; Kyprianou N
Mol Aspects Med; 2010 Apr; 31(2):205-14. PubMed ID: 20153362
[TBL] [Abstract][Full Text] [Related]
6. Anoikis and EMT: Lethal "Liaisons" during Cancer Progression.
Cao Z; Livas T; Kyprianou N
Crit Rev Oncog; 2016; 21(3-4):155-168. PubMed ID: 27915969
[TBL] [Abstract][Full Text] [Related]
7. Integrated Therapeutic Targeting of the Prostate Tumor Microenvironment.
Livas L; Hasani S; Kyprianou N
Adv Exp Med Biol; 2020; 1296():183-198. PubMed ID: 34185293
[TBL] [Abstract][Full Text] [Related]
8. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.
Altschuler J; Stockert JA; Kyprianou N
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672595
[TBL] [Abstract][Full Text] [Related]
9. AMPK/GSK3β/β-catenin cascade-triggered overexpression of CEMIP promotes migration and invasion in anoikis-resistant prostate cancer cells by enhancing metabolic reprogramming.
Zhang P; Song Y; Sun Y; Li X; Chen L; Yang L; Xing Y
FASEB J; 2018 Jul; 32(7):3924-3935. PubMed ID: 29505302
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeleton targeting value in prostate cancer treatment.
Martin SK; Kamelgarn M; Kyprianou N
Am J Clin Exp Urol; 2014; 2(1):15-26. PubMed ID: 25374905
[TBL] [Abstract][Full Text] [Related]
11. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
12. Anoikis molecular pathways and its role in cancer progression.
Paoli P; Giannoni E; Chiarugi P
Biochim Biophys Acta; 2013 Dec; 1833(12):3481-3498. PubMed ID: 23830918
[TBL] [Abstract][Full Text] [Related]
13. Targeting TUBB3 Suppresses Anoikis Resistance and Bone Metastasis in Prostate Cancer.
Dong B; Gu Y; Sun X; Wang X; Zhou Y; Rong Z; Zhang J; Shi X; Zhang Z; He X; Chen L; Xiong Q; Pang X; Cui Y
Adv Healthc Mater; 2024 May; ():e2400673. PubMed ID: 38809199
[TBL] [Abstract][Full Text] [Related]
14. Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance.
Archer M; Dogra N; Kyprianou N
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33076397
[TBL] [Abstract][Full Text] [Related]
15. Emerging therapeutics targeting castration-resistant prostate cancer: the AR-mageddon of tumor epithelial-mesenchymal transition.
Hendrix LN; Hamilton DA; Kyprianou N
Expert Rev Endocrinol Metab; 2013 Jul; 8(4):403-416. PubMed ID: 30736155
[TBL] [Abstract][Full Text] [Related]
16. Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway.
Zhang P; Chen L; Song Y; Li X; Sun Y; Xiao Y; Xing Y
Exp Cell Res; 2016 Oct; 347(2):350-9. PubMed ID: 27569004
[TBL] [Abstract][Full Text] [Related]
17. [Mechanism of prostate cancer invasion and metastasis].
Sakamoto S; Ichikawa T
Nihon Rinsho; 2014 Dec; 72(12):2086-9. PubMed ID: 25518338
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cells, Their Microenvironment and Anoikis.
Ayla S; Karahüseyinogluc S
Crit Rev Oncog; 2019; 24(1):27-34. PubMed ID: 31679217
[TBL] [Abstract][Full Text] [Related]
20. Understanding the cell survival mechanism of anoikis-resistant cancer cells during different steps of metastasis.
Khan SU; Fatima K; Malik F
Clin Exp Metastasis; 2022 Oct; 39(5):715-726. PubMed ID: 35829806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
